학술논문
9P GAIN PREDICTS OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH R‐GEMOX +/‐ ATEZOLIZUMAB. ARGO: A RANDOMISED PHASE II STUDY.
Document Type
Article
Author
Source
Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
Subject
Language
ISSN
02780232